Learning Objectives
- Discuss risks of malignancy in bariatric patients
- Contraindication to surgery due to Barrett’s debate
- Epidemiology of Barrett’s in bariatric surgery
- Endoscopic/pH studies pre/post operatively
8:45am |
Welcome John Morton, MD MPH FACS; Jaime Ponce, MD FASMBS |
8:50am |
Barrett’s esophagus: what is it? how frequent is in obese patients? Teresa LaMasters, MD |
9:05am |
Management of Barrett’s and risk of cancer Marina Kurian, MD FASMBS |
9:20am |
What is the incidence of “de novo” reflux and Barrett’s after sleeve? Anthony Petrick, MD FASMBS |
9:35am |
Are endoscopy and/or pH studies needed on every sleeve patient? John Morton, MD MPH FACS |
9:50am |
Panel: Q & A |
10:10am | Break |
10:25am |
Is reflux a contraindication for sleeve? (Pro vs. Con) Monique Hassan, MD FACS; Rami Lutfi, MD FACS FASMBS |
10:55am |
Is Barrett’s a contraindication for sleeve? (Absolute vs. Relative) Eric DeMaria, MD FASMBS; Raul Rosenthal, MD |
11:30am |
Post-op surveillance after Sleeve and management of reflux Mona Misra, MD FASMBS |
11:45am |
Panel: Q & A |
12:15pm | Adjourn |